Recently, various new classes of agents, which include next-generation androgen receptor (AR) signaling inhibitors (abiraterone, enzalutamide, apalutamide, and darolutamide), bone-targeting agents (radium-223 chloride, zoledronic acid), and poly(ADP-ribose) polymerase (PARP) inhibitors (olaparib, rucaparib, and talazoparib) have been developed to treat PCa
Stopping prematurely can lead to post-Semaglutide weight loss plateau, where the risk of weight regain increases
Preferred emulsifiers are sodium hyaluronate, Promulgen-D (a mixture of 75% cetostearyl alcohol and 25% ethoxylate cetostearyl alcohol sold by Amerchol Corp.), Arlacel 165 (Glyceryl Stearate and PEG-100 Stearate sold by Croda Inc.) silicone (Dow Corning 200 Fluid, 350 CST), dimethylaminoethanol, also known as DMAE, and Phospholipon 90 G (phosphatidylcholine with 10% fatty acids sold by Phospholipid GmbH)
Impacts on patients and providers Access to FDA-Approved medications: With the shortage resolved, patients should have better access to FDA-approved Semaglutide products
Ongoing coaching and support for sustainable lifestyle changes

Recommended articles Microbiome-Targeted Therapies as an Adjunct to Traditional Weight Loss Interventions: A Systematic Review and Meta-Analysis Peckmezian T, Garcia-Larsen V, Wilkins K, Mosli RH, BinDhim NF, John GK, Yasir M, Azhar EI, Mullin GE, Alqahtani SA Diabetes, Metabolic Syndrome and Obesity 2022, 15:3777-3798 Published Date: 11 December 2022 Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations Chao AM, Tronieri JS, Amaro A, Wadden TA Drug Design, Development and Therapy 2022, 16:4449-4461 Published Date: 29 December 2022 Baseline Serum BCAAs are Related to the Improvement in Insulin Resistance in Obese People After a Weight Loss Intervention Zhang C, Wang S, Wu Y, Guo Y, Wang X Diabetes, Metabolic Syndrome and Obesity 2023, 16:179-186 Published Date: 19 January 2023 The Benefit of Healthy Lifestyle in the Era of New Medications to Treat Obesity Dalle Grave R Diabetes, Metabolic Syndrome and Obesity 2024, 17:227-230 Published Date: 15 January 2024 Effect of Weight Loss on the Apnea Hypopnea Index is Related to Waist Circumference in Chinese Adults with Overweight and Obesity Ren Y, Cui X, Zhu X, Guo H, Zhou Q, Yuan P, Cheng H, Wu W Diabetes, Metabolic Syndrome and Obesity 2024, 17:453-463 Published Date: 27 January 2024
